Amerise Biosciences Ltd (AMERISE) — shareholding pattern, promoter holding, financials and share price
About Amerise Biosciences Ltd (AMERISE)
Amerise Biosciences Ltd operates in the Plastic Products - Industrial industry, within the Capital Goods sector. It trades on the NSE as AMERISE and on the BSE under scrip code 531681. Its ISIN is INE673C01020.
Incorporated in 1984, Amradeep Industries Ltd manufactured and traded in Decorative Boards, Laminates Sheets, Boards, and laminates products [1]
Amerise Biosciences Limited was originally incorporated as Amradeep Industries Limited in 1984, specializing in manufacturing construction and agricultural equipment.
Initially involved in commodity trading, Amerise shifted to trading castor seeds in 2007, illustrating its adaptability in various market segments.
Listed peers in Plastic Products - Industrial: Bloom Dekor Ltd, Pet Plastics Ltd, Krishna Filament Industries Ltd, Polymac Thermoformers Ltd, Noble Polymers Ltd, Integrated Thermoplastics Ltd.
Valuation & Returns
10 Jul 2026At ₹0.84 a share on 10 Jul 2026, Amerise Biosciences Ltd (AMERISE) was valued at a price-to-earnings ratio of 277.49x against an industry P/E of 37x and a price-to-book of 1.03x on a book value of ₹0.81 per share as of Mar 2025. Solomo computes return on equity of 0.37% and return on capital employed of 0.38% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 277.49x
- Industry P/E
- 37x
- P/B
- 1.03x
- Book value / share
- ₹0.81
- ROE
- 0.37%
- ROCE
- 0.38%
- ROA
- 0.24%
- Debt / equity
- 0x
- Dividend yield
- 0%
- 52-week range
- ₹0.5 – ₹0.94
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Amerise Biosciences Ltd (AMERISE) reported revenue of ₹0.26 crore and net profit of ₹0.02 crore. That compares with revenue of ₹0.19 crore and net profit of ₹0.01 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹0.08 crore and net profit ₹0.06 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 9.58 | 0.01 | 0.04 | 0.19 | 0.26 |
| Net profit (₹ cr) | 0.55 | -0.12 | -0.15 | 0.01 | 0.02 |
| EPS (₹) | 0.08 | -0.02 | -0.02 | 0 | 0 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | - | 375.00% |
| Profit growth | -78.19% | 106.67% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 0% of Amerise Biosciences Ltd (AMERISE) (unchanged from the previous quarter). Market capitalisation was ₹6 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: AMRAPALI INDUSTRIES LIMITED 4.4%, JAGKARTA AGENCIES PRIVATE LIMITED 4.11%, DRISTI FASHIONS PRIVATE LIMITED 4.09%, TWIST BARTER PRIVATE LIMITED 4.09%, SNEHA SANJEEV LUNKAD 3.78%, KAMNA COAL PRIVATE LIMITED 3.08%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 0% | - | - | - | 100% |
| Mar 2026 | 0% | - | - | - | 100% |
| Dec 2025 | 0% | - | - | - | 100% |
| Sep 2025 | 0% | - | - | - | 100% |
| Jun 2025 | 0% | - | - | - | 100% |
| Mar 2025 | 0% | - | - | - | 100% |
| Dec 2024 | 0% | - | - | - | 100% |
| Sep 2024 | 0% | - | - | - | 100% |